title: Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.
abstract: Chronic rhinosinusitis (CRS) encompasses a heterogeneous group of debilitating chronic inflammatory sinonasal diseases. Despite considerable research, the etiology of CRS remains poorly understood, and debate on potential roles of microbial communities is unresolved. Modern culture-independent (molecular) techniques have vastly improved our understanding of the microbiology of the human body. Recent studies that better capture the full complexity of the microbial communities associated with CRS reintroduce the possible importance of the microbiota either as a direct driver of disease or as being potentially involved in its exacerbation. This review presents a comprehensive discussion of the current understanding of bacterial, fungal, and viral associations with CRS, with a specific focus on the transition to the new perspective offered in recent years by modern technology in microbiological research. Clinical implications of this new perspective, including the role of antimicrobials, are discussed in depth. While principally framed within the context of CRS, this discussion also provides an analogue for reframing our understanding of many similarly complex and poorly understood chronic inflammatory diseases for which roles of microbes have been suggested but specific mechanisms of disease remain unclear. Finally, further technological advancements on the horizon, and current pressing questions for CRS microbiological research, are considered.
authors.affiliation: School of Biological Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: Michael
authors.initials: M
authors.lastname: Hoggard
authors.affiliation: School of Medicine, University of Auckland, Auckland, New Zealand.
authors.forename: Brett
authors.initials: B
authors.lastname: Wagner Mackenzie
authors.affiliation: School of Medicine, University of Auckland, Auckland, New Zealand.
authors.forename: Ravi
authors.initials: R
authors.lastname: Jain
authors.affiliation: School of Biological Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Taylor
authors.affiliation: School of Medicine, University of Auckland, Auckland, New Zealand.
authors.forename: Kristi
authors.initials: K
authors.lastname: Biswas
authors.affiliation: School of Medicine, University of Auckland, Auckland, New Zealand richard.douglas@auckland.ac.nz.
authors.forename: Richard G
authors.initials: RG
authors.lastname: Douglas
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D001419:Bacteria / Q000145:classification* / Q000254:growth & development / Q000302:isolation & purification; D018441:Biofilms; D002986:Clinical Trials as Topic; D005658:Fungi / Q000145:classification* / Q000254:growth & development / Q000302:isolation & purification; D006801:Humans; D012220:Rhinitis / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology; D012852:Sinusitis / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology; D016896:Treatment Outcome; D014780:Viruses / Q000145:classification / Q000254:growth & development / Q000302:isolation & purification
chemical_list: D000890:Anti-Infective Agents